Antiarrhythmic peptides

Details Antiarrhythmic peptides Antiarrhythmic peptides

2007-07-31

2007-07-31

Campell, Bruce (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S821000, C514S928000, C530S356000, C435S007210, C436S064000

Reexamination Certificate

active

09792286

ABSTRACT:
Disclosed are novel peptides including antiarrhythmic peptides that have improved stability. Further disclosed are compositions that include such peptides and methods of using the compositions particularly as medicaments.

REFERENCES:
patent: 4775743 (1988-10-01), Mimura et al.
patent: 19707854 (1998-09-01), None
patent: 0 214 659 (1987-03-01), None
patent: WO 96/21674 (1996-07-01), None
patent: WO 01/62775 (2001-08-01), None
patent: WO 02/077017 (2002-10-01), None
Y. Kohama, et al. “Effect on N-3-(4-Hydroxyphenyl) propionyl Pro-Pro-Gly-Ala-Gly on Calcium-Induced Arrhythmias”, Chemical & Pharmacuetical Bulletin, vol. 36, No. 11, 1988, pp. 4597-4599.
S. Dhein et al. “Therapeutic Potential of Antiarrhythmic Peptides”, Drugs, vol. 49, No. 6, 1995, pp. 851-855.
D. Kundu “Synthesis, conformational features and biological activity of Pro-3 antiarrhythmic peptide”, Collection of Czechoslovak Chemical Communications, vol. 54, No. 3, 1989, pp. 760-771.
B. Weinstein “Chemistry and Biochemistry of Amino Acids, Peptides and Proteins” 1982, Marcel Dekker Inc., New York and Basel, p. 357.

Affiliated with

Also associated with

Rating

Antiarrhythmic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiarrhythmic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarrhythmic peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3730402